This week Dr. Drew talks to Dr. Steven Radowitz, the Chief Medical Officer at the Nushama Psychedelic Wellness Center, a pioneer in ketamine-assisted therapy. Together, they delve into the pressing mental health issues post-pandemic, unraveling the intricacies of ketamine treatment and its efficacy. The discussion extends to the nuanced landscape of mood disorders and the evolving future of PTSD care. Drew and Steven also explore the intersection of drug addiction and celebrity, and reflect on the recent passing of Matthew Perry.
Please support the show by checking out our sponsors!
HVMN: You can save 30% off your first subscription order of Ketone-IQ at HVMN.com/DREW
Shopify: Sign up for a one-dollar-per-month trial period at SHOPIFY.COM/drew
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.